Cancer Communications
indexed by SCI
BMC

Important notice

 

 

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications 2021年影响因子突破15分

Cancer Communications 进入2021年中科院期刊分区表医学1区和肿瘤学1区

Cancer Communications 入选中国科协发布的高质量肿瘤学科技期刊T1分级目录

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells
Jang Hee Han, Yong Keon Kim, Hakhyun Kim, Jooyoung Lee, Myung Joon Oh, Sang Bum Kim, Minjee Kim, Kook Hwan Kim, Hyun Ju Yoon, Myung-Shik Lee, John D. Minna, Michael A. White, Hyun Seok Kim
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/15/2022   doi:10.1002/cac2.12332
Antibody variable region engineering for improving cancer immunotherapy
Hantao Lou, Xuetao Cao
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/13/2022   doi:10.1002/cac2.12330
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xinfeng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun, Jie He
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/11/2022   doi:10.1002/cac2.12327
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases
Pilar Fajardo, Maria Taskova, Miguel A. Martín-Serrano, Jonas Hansen, Sofie Slott, Anna K. Jakobsen, Marie-Louise Wibom, Be?at Salegi, Alberto Mu?oz, Antonio Barbachano, Arpita Sharma, John Mark Gubatan, Aida Habtezion, Juan J. Sanz-Ezquerro, Kira Astakhova, Ana Cuenda
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/7/2022   doi:10.1002/cac2.12331
Vitamin D3 for reducing mortality from cancer and other outcomes before, during and beyond the COVID-19 pandemic: A plea for harvesting low-hanging fruit
Hermann Brenner, Ben Sch?ttker, Tobias Niedermaier
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/6/2022   doi:10.1002/cac2.12328
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
Ajaz A. Bhat, Sabah Nisar, Mayank Singh, Bazella Ashraf, Tariq Masoodi, Chandra P. Prasad, Atul Sharma, Selma Maacha, Thasni Karedath, Sheema Hashem, Syed Besina Yasin, Puneet Bagga, Ravinder Reddy, Michael P. Frennaux, Shahab Uddin, Punita Dhawan, Mohammad Haris, Muzafar A. Macha
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 7/5/2022   doi:10.1002/cac2.12295
Low cholesterol biosynthesis favors epithelial-to-mesenchymal transition maintenance and influences tumor molecular subtyping and disease-free survival in colon cancer patients
Ana?s Aulas, Maria Lucia Liberatoscioli, Pascal Finetti, Olivier Cabaud, David J. Birnbaum, Lucas Usclade, Daniel Birnbaum, Fran?ois Bertucci, Emilie Mamessier
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/30/2022   doi:10.1002/cac2.12329
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma
Chang Zhang, Qi Sun, Xu Zhang, Na Qin, Zhening Pu, Yayun Gu, Caiwang Yan, Meng Zhu, Juncheng Dai, Cheng Wang, Ni Li, Guangfu Jin, Hongxia Ma, Zhibin Hu, Erbao Zhang, Fengwei Tan, Hongbing Shen
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/21/2022   doi:10.1002/cac2.12325
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines
Zhifu Sun, Xuewei Wang, Pete Vedell, Jean-Pierre Kocher
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/18/2022   doi:10.1002/cac2.12326
PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression
Hong-Yong Cui, Wei Wei, Mei-Rui Qian, Ruo-Fei Tian, Xin Fu, Hong-Wei Li, Gang Nan, Ting Yang, Peng Lin, Xi Chen, Yu-Meng Zhu, Bin Wang, Xiu-Xuan Sun, Jian-Hua Dou, Jian-Li Jiang, Ling Li, Shi-Jie Wang, Zhi-Nan Chen
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/18/2022   doi:10.1002/cac2.12322

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China